Breaking News

You are here » Indian-Commodity  :  Top News  :  Glenmark receives USFDA approval for generic version of Azor Tablets

07-Jul2017

Glenmark receives USFDA approval for generic version of Azor Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg, the generic version of Azor Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg, of Daiichi Sankyo, Inc.

According to IMS Health sales data for the 12 month period ending May 2017, the Azor Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg market achieved annual sales of approximately $211.6 million.

Glenmark's current portfolio consists of 119 products authorized for distribution in the US marketplace and 66 ANDA's pending approval with the USFDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.



Related News

View all news

Gold futures finish at one month low on Monday

Gold futures finished at one month low on Monday, with the increased risk appetite among investors improved stock markets and dulled bullion investments. Besides, a stronger dollar amid the anticipated......

Physical rubber prices ruled steady on Saturday

Physical Rubber prices ruled steady on Saturday due to buyer resistance in the market. Spot prices for RSS-4 and RSS-5 variety closed unchanged at Rs 125/ kg and Rs 120.50/ kg respectively.In the futures......

Gold futures trade almost steady on Monday

Gold futures traded almost steady on Monday, with cautious outlook from investors as they eyed on impending report from china showcasing dimmed economic growth to its slowest in 28 years in 2018 in face......

Top News

View all news

Coromandel International reports 14% fall in Q3 consolidated net profit

Coromandel International has reported results for third quarter ended December 31, 2018.The company has reported a fall of 15.23% in its net profit at Rs 152.67 crore for the quarter under review as compared......

Bajaj Auto planning to foray into electric vehicles next year

Bajaj Auto is planning to foray into electric vehicles (EV) next year, simultaneously with the migration of its conventional engine vehicles to BS-VI emission norms.The company also plans to launch electric......

Inflame Appliances, Lupin and IDBI Bank to see some action today

Inflame Appliances has set up a new facility to produce Electrical Chimneys & its parts, which can be considered as an 'Make in India' initiative as more than 90% Chimneys are imported from China......